V023-1851 Screening compound: 1-[3-(3,4-dimethoxyphenyl)-5-(2-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-2-(2-methylpiperidin-1-yl)ethan-1-one

V023-1851 Screening compound: 1-[3-(3,4-dimethoxyphenyl)-5-(2-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-2-(2-methylpiperidin-1-yl)ethan-1-one
V023-1851 Screening compound: 1-[3-(3,4-dimethoxyphenyl)-5-(2-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-2-(2-methylpiperidin-1-yl)ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound V023-1851
1-[3-(3,4-dimethoxyphenyl)-5-(2-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-2-(2-methylpiperidin-1-yl)ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V023-1851

Molecular Formula

C26H33N3O4 (C26 H33 N3 O4)

Compound Name

1-[3-(3,4-dimethoxyphenyl)-5-(2-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-2-(2-methylpiperidin-1-yl)ethan-1-one

IUPAC name

1-[3-(34-dimethoxyphenyl)-5-(2-methoxyphenyl)-45-dihydro-1H-pyrazol-1-yl]-2-(2-methylpiperidin-1-yl)ethan-1-one

SMILES

CC1N(CC(N(C(C2)c(cccc3)c3OC)N=C2c(cc2)cc(OC)c2OC)=O)CCCC1

InChI

InChI=1S/C26H33N3O4/c1-18-9-7-8-14-28(18)17-26(30)29-22(20-10-5-6-11-23(20)31-2)16-21(27-29)19-12-13-24(32-3)25(15-19)33-4/h5-6,10-13,15,18,22H,7-9,14,16-17H2,1-4H3

InChI Key

PSYVTTRWVBQWEP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19887077

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

451.57

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.003

Distribution Coefficient, logD

3.649

Water Solubility, LogSw

-4.20

Polar Surface Area

52.933

Acid Dissociation Constant (pKa)

19.12

Base Dissociation Constant (pKb)

7.50

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

46.20

V023-1851 in Drug Discovery

Included in Screening Libraries

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
Targets:
  • GPCR
  • Ion Channels

References: we are preparing a list of scientific research reports with V023-1851 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V023-1851?
Check Price and Availability of V023-1851, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V023-1851 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V023-1851
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V023-1851
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V023-1851 available by request